Arcus acquired a majority stake in FixMap in September Net is the second add-on under Arcus’ ownership FixMap is a Polish FTTH operator founded in 2018 Arcus Infrastructure Partners portfolio ...

Arcus Biosciences (NYSE:RCUS) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Arcus ...

Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. In partnership with industry ...

If you want to know who really controls Arcus Biosciences, Inc. (NYSE:RCUS), then you'll have to look at the makeup of its share registry. With 51% stake, institutions possess the maximum shares ...

A new report out today from anti-ransomware and cyber resilience platform provider Halcyon Tech Inc. details the increasingly sophisticated techniques used by the Arcus Media ransomware group.

With new data out on Arcus Biosciences’ experimental HIF-2a inhibitor, one group of analysts figures the company could give Merck’s Welireg a run for its money in kidney cancer. In the phase 1 ...

Arcus Infrastructure Partners has acquired a majority stake in FixMap, a Warsaw-based fiber-to-the-home business. This is the sixth acquisition for Arcus’ third fund, AEIF3, and Arcus’ third ...

Gilead Sciences and Arcus Biosciences have amended their collaboration agreement, the companies announced Monday, with Gilead making an additional equity investment of $320 million and raising its ...

Jan 29 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Monday it has raised its stake in Arcus Biosciences (RCUS.N), opens new tab to 33% and expanded its presence in the drug ...

Arcus Infrastructure Partners has acquired a German data center operator and launched a new European data center platform. The investment company this week announced the acquisition of Internet Port ...

The new Collins Aerospace Arcus image generator displayed at I/ITSEC 2023. (Giles Ebbutt) Collins Aerospace, an RTX business, has developed a new image generator (IG) called Arcus and launched it ...

Arcus Biosciences Inc (NYSE:RCUS) recently saw a daily gain of 27.7% and a 3-month gain of 29.03%. However, with a Loss Per Share of 3.96, is the stock truly undervalued? This article provides a ...